Literature DB >> 32165150

Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats.

Chiomah Ezeomah1, Kathryn A Cunningham2, Sonja J Stutz3, Robert G Fox3, Natalya Bukreyeva1, Kelly T Dineley4, Slobodan Paessler1, Irma E Cisneros5.   

Abstract

Opioid use disorder (OUD) affects over two million in the United States and is an increasing public health crisis. The abuse of fentanyl and the emergence of potent fentanyl derivatives increases the risk for the user to succumb to overdose, but also to develop OUD. While intense attention is currently focused on understanding the complexity of behaviors and neural functions that contribute to OUD, much remains to be discovered concerning the interactions of opioid intake with the immune response in the central nervous system (CNS). In the present studies, we tested the hypothesis that short-term abstinence from fentanyl self-administration associates with altered expression of innate immune markers. Male Sprague-Dawley rats were trained to self-administer fentanyl (0.0032 mg/kg/infusion) to stability followed by 24 h of abstinence. Several innate immune markers, as well as opioid receptors (ORs) and intracellular pattern recognition receptors (PRRs), were interrogated within nodes of the neurocircuitry involved in OUD processes, including the prefrontal cortex (PFC), nucleus accumbens (NAc), caudate putamen (CPu), hippocampus (HIP) and midbrain (MB). In the present study, few immune targets were impacted in the PFC and MB during short-term abstinence from fentanyl (relative to saline) self-administration. However, increased expression of cytokines [e.g., interleukin (IL)1β, IL5], chemokines [e.g., C-C motif chemokine 20 (MIP3α)], tumor necrosis factor α (TNFα) and interferon (IFN) proteins (e.g., IFNβ and IFNγ)] was seen in the NAc, while decreased expression of cytokines (e.g., several ILs), chemokines [e.g., granulocyte-macrophage colony-stimulating factor (GMCSF), monocyte chemoattractant protein (MCP) MCP1, MIP3α], the chemokine ligand 5 (RANTES) and interferons (e.g., IFNβ and IFNγ) in the HIP. Positive correlations were observed between cumulative fentanyl intake and expression of IL1β and IL6 in the NAc, and significant negative correlations with fentanyl intake and IFN β, IL2, IL5, IL12p70 and IL17 in the HIP. Few changes in OR expression was observed during early abstinence from fentanyl self-administration. Excitingly, the expression of the PRR, stimulator of interferon genes (STING) negatively correlated with cumulative fentanyl intake and significantly correlated to specific cytokines, chemokines and interferon proteins in the HIP. Although the CPu appears relatively invulnerable to changes in innate immune markers, the highest correlations between cumulative fentanyl intake with MAVS and/or STING was measured in the CPu. Our findings provide the first evidence of CNS innate immune responses and implicate STING as novel mechanistic targets of immunomodulation during short-term abstinence from fentanyl self-administration.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Fentanyl; Innate immunity; MAVS; Opioid receptors; Opioid use disorder; STING; Self-administration

Mesh:

Substances:

Year:  2020        PMID: 32165150     DOI: 10.1016/j.bbi.2020.03.003

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  8 in total

1.  Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 Tesla.

Authors:  Sarah L Withey; Lei Cao; Fernando B de Moura; Kenroy R Cayetano; Michael L Rohan; Jack Bergman; Stephen J Kohut
Journal:  Brain Imaging Behav       Date:  2022-02-28       Impact factor: 3.224

2.  Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats.

Authors:  Andrew D Gaulden; Nicole Burson; Nareen Sadik; Ishita Ghosh; Sabrina J Khan; Susanne Brummelte; Srinivasu Kallakuri; Shane A Perrine
Journal:  Drug Alcohol Depend       Date:  2021-09-24       Impact factor: 4.852

Review 3.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

4.  Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking behavior in male rats.

Authors:  Ruyan Wu; Jianfeng Liu; Jimmy Vu; Yufei Huang; David M Dietz; Jun-Xu Li
Journal:  Brain Behav Immun       Date:  2021-12-24       Impact factor: 7.217

5.  A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.

Authors:  Yafang Zhang; Suditi Rahematpura; Kael H Ragnini; Amanda Moreno; Kamryn S Stecyk; Michelle W Kahng; Brandon T Milliken; Matthew R Hayes; Robert P Doyle; Heath D Schmidt
Journal:  Neuropharmacology       Date:  2021-05-11       Impact factor: 5.273

Review 6.  Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Authors:  Mark D Namba; Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive; Janet L Neisewander
Journal:  Front Neurosci       Date:  2021-04-15       Impact factor: 4.677

Review 7.  Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Authors:  Hanis Mohammad Hazani; Isa Naina Mohamed; Mustapha Muzaimi; Wael Mohamed; Mohamad Fairuz Yahaya; Seong Lin Teoh; Rashidi Mohamed Pakri Mohamed; Mohd Fadzli Mohamad Isa; Sundus Mansoor Abdulrahman; Ravi Ramadah; Mohammad Rahim Kamaluddin; Jaya Kumar
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

8.  Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.

Authors:  Chiomah Ezeomah; Chanida Fongsaran; Amanda L Persons; T Celeste Napier; Irma E Cisneros
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.